Marshall Wace’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-440,254
| Closed | -$11.9M | – | 3063 |
|
|
2024
Q2 | $11.9M | Buy |
440,254
+63,139
| +17% | +$1.31M | 0.02% | 655 |
|
|
2024
Q1 | $6.91M | Buy |
377,115
+11,713
| +3% | +$186K | 0.01% | 869 |
|
|
2023
Q4 | $4.48M | Sell |
365,402
-612,559
| -63% | -$5.75M | 0.01% | 948 |
|
|
2023
Q3 | $14.7M | Sell |
977,961
-123,742
| -11% | -$2.57M | 0.03% | 522 |
|
|
2023
Q2 | $35.8M | Buy |
1,101,703
+360,239
| +49% | +$13.2M | 0.07% | 295 |
|
|
2023
Q1 | $29M | Buy |
741,464
+424,811
| +134% | +$20.8M | 0.06% | 333 |
|
|
2022
Q4 | $16.7M | Buy |
316,653
+273,014
| +626% | +$13.3M | 0.04% | 535 |
|
|
2022
Q3 | $1.97M | Buy |
+43,639
| New | +$1.88M | ﹤0.01% | 2033 |
|
|
2022
Q1 | – | Sell |
-7,806
| Closed | -$333K | – | 4181 |
|
|
2021
Q4 | $333K | Buy |
+7,806
| New | +$391K | ﹤0.01% | 2989 |
|
|
2021
Q2 | – | Sell |
-41,288
| Closed | -$2.09M | – | 3203 |
|
|
2021
Q1 | $2.09M | Sell |
41,288
-428,134
| -91% | -$23.8M | 0.01% | 1308 |
|
|
2020
Q4 | $29.6M | Buy |
+469,422
| New | +$29.1M | 0.16% | 127 |
|
|
2020
Q3 | – | Sell |
-9,876
| Closed | -$414K | – | 1997 |
|
|
2020
Q2 | $414K | Buy |
+9,876
| New | +$379K | ﹤0.01% | 1254 |
|
Other funds holding SILK
Marshall Wace's SILK Position: Q3 2024 in Review
Marshall Wace sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 440,254 shares — an estimated $11.9M sold.
Marshall Wace first reported a position in SILK in Q2 2020 and held it in 12 quarters. The position peaked at $35.8M in Q2 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Marshall Wace reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Marshall Wace sold 440,254 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $11.9M.
- Marshall Wace first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
- Marshall Wace's Silk Road Medical, Inc. Common Stock position peaked at $35.8M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.